Tag: regulation

  • Uphill Battle

    Uphill Battle

    Credit: Pormezz

    The motives behind successful quitting require ongoing efforts to understand those reasons.

    By George Gay

    Two Hong Kong news stories published in March provided examples of what, to me, is officialdom’s often muddled thinking around tobacco smoking issues. For instance, there is a belief system operating among some politicians that has it that though the consumption of cigarettes is “addictive,” smokers will quit smoking when the price of cigarettes is raised.

    Such beliefs seem to gloss over a few inconvenient facts. The first is that while “addictive” is a Humpty Dumpty word often used to mean whatever the person using it wants it to mean, most definitions include the idea of compulsion, and, bizarrely, politicians, egged on by tobacco control advocates, have hammered home the idea that smoking compulsion is extremely difficult if not impossible to break.

    So the question arises: What leads politicians to believe that raising the price of cigarettes will overcome this compulsion, which is unrelated to price?

    Another pertinent question would be why so many politicians, apparently convinced that nicotine addiction is almost unbreakable, are not willing to accept the concept of tobacco harm reduction (THR), whereby users continue to consume the addictive nicotine, which is what they crave and which, alone, does not cause harm, but without the harmful products produced during the burning of tobacco.

    This question was raised a long time ago by the availability of vapes, but it has surely been elevated to another level by the arrival of nicotine pouches. What appeared to be a blinkered attitude by some politicians and tobacco control advocates has been raised to the level of pigheaded obstinacy.

    Why? Muddled thinking again, perhaps brought on because of the science, if you can call it that. According to a study by the Ohio State University Comprehensive Cancer Center, nicotine pouches do little to curb smokers’ nicotine cravings. A university press note from Nov. 21 said that researchers had “found that current smokers had a much greater spike of nicotine in their blood levels and much sharper relief from craving symptoms when smoking than when using both the low-dose and higher dose nicotine pouches.”

    I ask you, what is the average politician going to make of this? They are going to say that given these pouches do not work, we may as well ban them and prevent another nicotine product from entering the market, and, without mentioning it, support the continuing use of cigarettes.

    They will not stop to ask themselves whether the science here might be somewhat askew. They will not stop to ask themselves why, if nicotine pouches do not work, there is purportedly a “problem” with increasing sales. They will not stop to ask themselves whether judgments about the efficaciousness of these products are best left to the market rather than the laboratory. And they will not stop to ask themselves whether consumers need scientists to tell them whether nicotine pouches work for them.

    Of course, they will not ask these questions because they are unlikely to see beyond the heading: “Pouches do little to curb cravings: Study.” And this a pity because the press note about the study was not totally negative regarding nicotine pouches.

    “Our challenge is to approach regulation of nicotine pouches to limit their appeal among young people while making them more appealing to adult smokers who would see health benefits by switching from cigarettes—which have the most severe health impacts with long-term use—to nicotine pouches,” the lead study author, Brittney Keller-Hamilton, was quoted as saying.

    I say not totally negative because what is being called for here is a balance between designing nicotine pouches. Hence, they are effective in getting smokers to quit while not allowing them to become attractive to the underaged. This is the self-same quest that has been pursued in the case of vapes, always with the same result: that the products are made less attractive to adult smokers than they need to be to encourage wholesale quitting.

    What comes out of the university worries me also because of an email I received on Oct. 6 from Mediasourcetv, which said the university was continuing its commitment to helping the U.S. Food and Drug Administration better regulate tobacco products. “The Ohio State University was one of seven centers across the United States selected to conduct research aimed at gathering scientific evidence needed for these decisions,” the email said.

    Don’t get me wrong. I am all in favor of the FDA making better decisions about tobacco and nicotine products. In fact, I shall wait with baited breath for this to happen. No, the problem was what came next in the second paragraph.

    “Historically, the tobacco industry has manipulated nicotine in combustible cigarettes and smokeless tobacco products, like chewing tobacco, to sustain dependence among existing users but also to increase their appeal and addictiveness for young people and nonusers,” the email said.

    Firstly, I don’t like the starting point that says, historically, the tobacco industry has manipulated nicotine. This seems to indicate the university, assuming it was the source of the story, is starting from a rather strange position from which it will be difficult to generate objective scientific evidence. How can it be that what happened “historically” can impinge scientifically on the present situation?

    Either you are a scientist or a historian. It is quite possible that nobody still works for the tobacco industry who was involved in manipulating nicotine, so the question arises as to what the link is between the industry of yore and that of today.

    Secondly, I get caught up with the finale: “… but also to increase their appeal and addictiveness for young people and nonusers.” How can it possibly be the case that manipulating nicotine increases the appeal and addictiveness of tobacco products to nonusers? This is utter nonsense.

    These might seem like minor points, but you have a responsibility to take care of what you say when you are writing about what is generally thought to be the product whose consumption causes more preventable disease and death than the consumption of any other consumer product. Otherwise, you cannot be surprised if people dismiss everything you say as gibberish.

    On which point, let me flip back to the middle of the sentence: “like chewing tobacco.” The word “like” here is misleading because it seems to mean something similar to but not the same as. What should have been written, I guess, is “such as chewing tobacco.”

    But I digress. The second inconvenient fact about the worth of raising taxes and, therefore, cigarette prices is that many of the smokers who would otherwise be further impoverished by cigarette price rises probably know where they can buy illicit products that undercut the price of tax-paid cigarettes.

    Indeed, one of the stories on the English-language news website RTHK.com quoted Hong Kong politicians as saying that it was common to see people on public housing estates handing out flyers promoting illicit tobacco products.

    Of course, legislators and the tobacco industry get on their high horses and condemn the purchase of illicit products as somehow morally wrong, but if you are involved in promoting a system where a licit, “addictive” product is deliberately made unaffordable to many of the people within the minority group comprising smokers, you can hardly take the moral high ground. You are the problem.

    The third inconvenient fact is that some smokers, probably a minority of them, can afford to pay the increased prices. And this raises an odd question: Do price increases discriminate against the well off? Let me explain. If politicians really believe that raising the prices of cigarettes will cause people to quit smoking and that quitting will improve the former smokers’ life chances, unless those price rises are enough to cause the richest smokers to quit, then the wealthiest smokers are being discriminated against; they are not being forced into improving their life chances as are poorer smokers.

    Clearly, the only way to bring in a fair system would be to ask all smokers to pay for their cigarettes a price that would be unaffordable even to the richest among their ranks, and, perhaps, to stop nonsmokers from being tempted to take up the habit, the price would have to make cigarettes unaffordable even for the wealthiest person in the country. I think this is called prohibition.

    This might seem like a phantasmic approach, but I do not think it would be much more unreasonable than what happens in Hong Kong, where the authorities during the past couple of years have worried about the damage caused by smoking, used the taxation system to raise the prices of cigarettes and then worried about the increase in sales of illicit cigarettes.

    And when I say “worried,” this is something of an understatement if newspaper stories are anything to go by. The trade of illicit cigarettes is an obsession with endless stories about the quantities and the so-called values of seizures and the incidents of fines and prison sentences handed out to those seen to be breaking the law, even to individuals importing a few cigarettes on which local duties have not been paid.

    One suggestion put forward to help combat this trade has been to require that cigarettes bear customs department labels to show that duty has been paid on them. But this would surely be a sticking-plaster response. Those involved in the illegal trade could knock out labels capable of fooling most people.

    Only those with specialist knowledge and equipment who got up close and personal would know the difference. Clearly, consumers would know the labels and the products were not genuine—they could tell by the product’s price.

    What I find so odd is that authorities will go to all this bother when there is a way of encouraging smokers to quit their habit rather than bludgeoning them into submission—of working with consumers rather than against them. All that needs to happen is for the authorities to remove the ban on alternative, less-risky nicotine products.

    This would make sense—a lot more sense than is to be found in current policies because to try to use pricing to force people to break cigarette smoking addiction when they are not allowed to access acceptable alternative products and when there is a ready supply of illicit products seems to be the triumph of hope over experience.

    The pity is that I sense there are people in authority in Hong Kong who, while they might not be advocating THR yet, could be persuaded that this is the way ahead in the 21st century. I say this because the two stories mentioned at the start of this piece quoted rational voices alongside those of politicians who clearly would never have the courage to admit they had been wrong.

    Some politicians, while aiming to encourage people to quit smoking, obviously understand the difficulties involved and the necessity of treating smokers as ends in themselves, not as a means to an end. The RTHK.com story had two politicians pointing out that government efforts to combat the illegal trade in cigarettes were inadequate given two consecutive years of tax increases on these products and the difficulty in dealing with the trade in illicit products, especially that conducted through overseas websites.

    At the same time, a voice from the retail and wholesale sector quoted in The Standard made the point that the government should focus on better education about the harmful effects of cigarette smoking rather than relying on duty increases alone.

    And a politician also quoted in The Standard called on the government to enhance assistance to people wanting to quit smoking. Calls to a smoking cessation hotline, she said, had increased significantly since the latest tax increase, which had probably caused stress among some smokers. She added that there was a need for continuous efforts to understand the reasons behind successful quitting and the challenges faced by those who failed.

    There is hope, but it will be an uphill battle.

  • New UK Study Offers Insights Into Youth Vaping

    New UK Study Offers Insights Into Youth Vaping

    Photo: Daisy Daisy

    A new study has provided an in-depth look into the rising trend of disposable vape use among young people in the U.K.

    Led by the University of East Anglia and published in Addiction, the research reveals that young people see smoking and vaping as interchangeable, but are far more aware of the potential harms of vaping than they are of the dangers of smoking.

    The findings also suggest that banning disposable vape products or increasing their prices could lead young people to revert to smoking tobacco.

    Many of the young people questioned also believed that if disposable vapes were banned, they would be able to continue using them by stockpiling or purchasing illegally.

    “Youth use of disposable vapes has surged in recent years in the U.K.,” said lead researcher Caitlin Notley, a professor of addiction sciences at UEA’s Norwich Medical School, in a statement.

    “Despite this increase, little was previously known about the motivations behind this trend and the experiences of young people who use these products.

    “This study aimed to explore these aspects, providing valuable insights into the factors influencing youth vaping behavior.”

    The study recruited 29 young people aged between 16 and 20 and a range of methods were used to probe their motivations, experiences and perceptions of using disposable vapes.

    Each approach was chosen to best suit the needs of the participant—from individual interviews with researchers, to recorded conversations in friendship pairs using prompt cards without a researcher present, to small group interviews designed to support those with special educational needs.

    The key findings include:

    • Individual motivations: Participants highlighted key characteristics of disposable vapes that appealed to them, such as affordability, ease of access, and the attractive designs, colors, names, and flavors.
    • Behavior patterns: Many young people engaged in both vaping and tobacco smoking, viewing these behaviors as interchangeable based on the context. There was a common misconception about the relative harms of vaping compared to smoking.
    • Social and emotional factors: Experimentation with vapes was prevalent, and many young people used vapes to manage stress and anxiety. Vaping was also identified as a social activity, widely accepted among peer groups. Notably, participants were more informed about the potential harms of vaping than those associated with smoking.
    • Regulation: Strict regulatory measures, such as banning disposable vape products or increasing their prices, could lead young people to revert to smoking tobacco. Many of the young people believed that if disposable vapes were banned, they would be able to continue using them by stockpiling or purchasing illegally.

    “Disposable vapes are particularly attractive and accessible to young people in the U.K, contributing to the normalization of vaping within this demographic,” said co-author Ian Pope, from UEA’s Norwich Medical School. “Despite recognizing the potential health risks, young people continue to engage in both vaping and smoking, often interchangeably.

    “The widespread availability of underage vape sales and availability of illicit vapes further exacerbates this issue.”

    The researchers say the study suggests that young people’s use of disposable vapes could be reduced by tighter enforcement of age of sale and restricting packaging and marketing.

    However, they also say the evidence suggests these sorts of interventions have the potential for significant unintended consequences, including increased use of illicit vapes and increased tobacco use amongst young people.

    “Therefore any interventions to combat use of disposables may need to be accompanied by policy interventions to reduce access to illicit vapes and tobacco and increase awareness of the relative harms of tobacco compared to vapes,” said Notley.

    The research was conducted in partnership with the Norfolk and Norwich University Hospital and the Nicotine, Tobacco and Vaping Research Group at London South Bank University.

    The study was funded by the Norfolk and Norwich University Hospital Foundation Trust through the National Institute for Health and Care Research’s Research Capability Fund.

  • FDA Bans Boosted From Doing Vape Business in US

    FDA Bans Boosted From Doing Vape Business in US

    The United States District Court for the District of Colorado entered a consent decree of permanent injunction against Boosted (who also does business as Boosted E-Juice, Boosted and Live Boosted) and Cory Vigil, owner of Boosted LLC.

    To avoid litigation, the defendants signed a consent decree, which is a written agreement signed by a federal judge and entered as a court order. Under the consent decree, the defendants have agreed not to manufacture, sell, or distribute any new tobacco products until they meet certain requirements.

    These requirements include that the new tobacco products receive FDA marketing authorization, that FDA inspect the defendants’ facilities to determine compliance with the law, and that FDA notify defendants in writing that they appear to be in compliance with the law.

    According to the complaint filed by the U.S. Department of Justice (DOJ) on FDA’s behalf, defendants were previously warned that failing to obtain marketing authorization from FDA violated the Federal Food, Drug, and Cosmetic Act’s (FD&C Act) premarket review requirements for manufacturing, selling, and distributing new tobacco products.

    The agency’s warnings noted that continued violations could lead to further action, including an injunction, according to a release.

    “FDA remains steadfast in our work to enforce the law, especially after we’ve given a crystal-clear warning and explanation of what firms need to do to comply,” said Brian King, director of FDA’s Center for Tobacco Products (CTP). “Those who flout the law are responsible for the consequences, and we are committed to using the full force of our authorities to hold them accountable.”

    This case represents the ongoing collaboration among federal partners—which will continue and expand under FDA and DOJ’s newly announced task force—to address unauthorized e-cigarettes in the United States. This is the eighth time FDA and DOJ have initiated injunction proceedings, the first of which occurred in October 2022, to enforce the FD&C Act’s premarket review requirements for new tobacco products.

    DOJ institutes judicial enforcement actions under the FD&C Act in court. Accordingly, DOJ, on behalf of FDA, filed the consent decree of permanent injunction against the defendants in the District of Colorado, the manufacturer’s respective U.S. District Court.

    “FDA has made clear it is committed to working with our federal partners, including the U.S. Department of Justice, to take enforcement actions, like seeking permanent injunctions, against those who violate the law,” said Jill Atencio, acting director of CTP’s Office of Compliance and Enforcement. “A coordinated, all government approach that brings together collective federal resources and experiences is critical to the success of these enforcement actions.”

    The action is part of FDA’s comprehensive approach to enforcing the law in coordination with federal partners. Last year, FDA coordinated with U.S. Customs and Border Protection to seize more than $18 million in unauthorized e-cigarettes during a joint operation at LAX airport.

  • FDA Warns Sellers of ‘Drug Bottle’ Vaping Devices

    FDA Warns Sellers of ‘Drug Bottle’ Vaping Devices

    The US Food and Drug Administration has sent warning letters to six online retailers for selling unauthorized e-liquid products from the Bad Drip brand that imitate prescription drug bottles.

    The retailers were also warned for selling unauthorized flavored, disposable vaping products, including those under the brand names Funky Republic and HQD, according to an FDA release.

    “It boggles the mind that someone thought it was a good idea to package a tobacco product to look like a prescription drug bottle,” said Brian King, director of FDA’s Center for Tobacco Products. “There’s no place for this gratuitous and blatantly dangerous packaging, and FDA is committed to taking action against the illegal sale of these products.”

    In a Senate Judiciary meeting yesterday, King noted that products like Elf Bar cannot legally be sold in China because the government there has banned non-tobacco flavored e-cigarettes. Outraged that brands banned in China are sold in the U.S., Texas Senator John Cornyn vowed to introduce legislation to rectify that situation.

    Jefferies analyst Owen Bennett said the Congressional testimony could spur the FDA to approve more products from British American Tobacco and Juul. “This hearing is another example of increasing political pressure for the FDA to act” against unauthorized products, he said in a research note quoted by Bloomberg.

  • FDA, DOJ Grilled for ‘Unserious’ Action on Illegal Vapes

    FDA, DOJ Grilled for ‘Unserious’ Action on Illegal Vapes

    Photo: Katherine Welles

    U.S. Senators criticized top health and law enforcement officials for their failure to tame the rapidly growing illicit e-cigarette market, reports the Associated Press.

    During a hearing on June 12, lawmakers on the Senate Judiciary Committee questioned officials from the Food and Drug Administration and Department of Justice (DOJ) about attempts to manage the vaping market, which has grown to include thousands of flavored, unauthorized e-cigarettes imported from in China.

    To date, the agency has approved only a handful of e-cigarettes as alternatives for adult smokers. All other products on the market, including popular products like Juul, are pending review or considered illegal by regulators.

    “I simply do not understand how FDA and DOJ have permitted thousands of products to remain on store shelves when their manufacturers have not received authorization, or, in some cases, even filed an application,” said the committee’s chairman, Dick Durbin.

    Brian King, director of the FDA Center for Tobacco Products, said the agency has been slowed by a backlog of applications submitted by vape companies seeking approval to sell their products in the U.S. The FDA received millions of premarket tobacco product applications, each of which must be scientifically reviewed.

    An industry lobbyist told the committee that the FDA has created an untenable marketplace by rejecting more than 99 percent of applications submitted by companies.

    I simply do not understand how FDA and DOJ have permitted thousands of products to remain on store shelves when their manufacturers have not received authorization, or, in some cases, even filed an application.

    Ahead of the congressional hearing, several government agencies, including the FDA and the DOJ established a task force to better coordinate the fight against illegal e-cigarettes. Republican Senator Thom Tillis called the timing of the announcement “a political stunt,” and criticized the absence of other federal agencies from the initiative, including Customs and Border Protection (CBP).

    “If the timing of the task force formation wasn’t evidence of how unserious the FDA is about tackling the flood of illicit e-cigarettes, FDA’s exclusion of CBP from the task force makes it crystal clear,” said Tillis, who represents North Carolina, a major tobacco-producing state. He urged officials to concentrate enforcement on Chinese brands, rather than large domestic manufacturers like Reynolds American, which is based in North Carolina.

    The FDA can conduct investigations and recommend cases, but only the Justice Department can bring lawsuits. The FDA has sent hundreds of warning letters to vape shops and e-cigarette manufacturers in recent years. But the letters have done little to dissuade companies from flouting FDA rules and introducing new vapes.

    Disposable vapes account for an estimated 30 percent to 40 percent of the roughly $7 billion-dollar U.S. vaping market. The two best-selling disposables—Breeze and Elf Bar—generated more than $500 million in sales last year, according to Nielsen retail sales data analyzed by Goldman Sachs.

    Both brands have been sanctioned by FDA regulators but remain widely available, in some cases with new names, logos and flavors.

    King noted that products like Elf Bar cannot legally be sold in China because the government there has banned non-tobacco flavored e-cigarettes. Outraged that brands banned in China are sold in the U.S., Texas Senator John Cornyn vowed to introduce legislation to rectify that situation.

    Jefferies analyst Owen Bennett said the Congressional testimony could spur the FDA to approve more products from British American Tobacco and Juul. “This hearing is another example of increasing political pressure for the FDA to act” against unauthorized products, he said in a research note quoted by Bloomberg.

  • US Senate Hearing on Vaping ‘Epidemic’ Today

    US Senate Hearing on Vaping ‘Epidemic’ Today

    Senator Dick Durbin
    Credit: Dick Durbin

    The US Senate Judiciary Committee plans to conduct hearings today at 10 am on “Combatting the Youth Vaping Epidemic by Enhancing Enforcement Against Illegal E‑Cigarettes.” The hearing will be chaired by Senator Dick Durbin, a longtime opponent of vaping products.

    The hearing will take place just two days after the Justice Department and Food and Drug Administration announced they have created a multi-agency coalition of law enforcement organizations, including the Bureau of Alcohol, Tobacco, Firearms, and Explosives, the US Marshals Service, the Federal Trade Commission, and the US Postal Service, to pursue the underground trade in vaping materials.

    The federal task force will focus on several topics, including investigating and prosecuting new criminal, civil, seizure and forfeiture actions under the PACT Act; the Federal Food, Drug, and Cosmetic Act (FDCA), as amended by the Family Smoking Prevention and Tobacco Control Act (TCA); and other authorities.

    “The U.S. Marshals Service Asset Forfeiture Division stands ready to work with our Task Force partners in the seizure of unauthorized e-cigarettes from domestic distributors seeking to sell them unlawfully,” said Ronald Davis, director of the U.S. Marshals Service.

    Both the legislative and executive branches are in a hurry to solve the teen vaping epidemic before the public realizes that there isn’t one, according to media reports.

    As Michelle Minton wrote for the Reason Foundation last December, “The youth vaping epidemic, declared by the Food and Drug Administration in 2018, appears now to have been more of a teenage fad—one possibly partially fueled by media attention on the issue. But, while the vaping fad may be subsiding, the hysteria surrounding it continues unabated.”

  • Regulators Urged to Embrace Harm Reduction

    Regulators Urged to Embrace Harm Reduction

    More than 1.8 million lives could be saved within the next 40 years by replacing World Health Organization-directed tobacco control efforts with products like vapes and e-cigarettes, snus and nicotine pouches, a new study has found. Urgent action is required to tackle continuing prevalence of smoking as global efforts to end smoking have stalled and current approaches to tobacco control have proven insufficient, the researchers said.

    Instead of current measures, researchers found that tobacco harm reduction (THR) products that replace smoking with nicotine alternatives promise to make a significant improvement in health outcomes in the Middle East and save millions of lives.

    The researchers studied the impact of tobacco use in seven countries in the Middle East including Pakistan, Egypt, Lebanon, Jordan, Kuwait, Saudi Arabia and the UAE, and determined that more than 384,000 die prematurely annually due to tobacco use. Tobacco use contributes to several major causes of death in these countries including lung and oral cancer, COPD, heart disease, and stroke, which are all set to increase in prevalence over the next few decades.

    The ideal means of reducing this burden is through THR products which use nicotine without the deadly byproducts that cause disease. THR products like e-cigarettes/vapes, heated tobacco products, snus, nicotine pouches and charcoal free shisha are rapidly gaining traction among consumers in the Middle East and are considerably safer than smoking. However, these innovations have not yet been embraced by physicians and governments as means of cutting premature deaths. 

    Embracing THR, cessation, and improved lung cancer treatment represents a major opportunity for the Middle East to dramatically improve the health of its populations.

    The report comes as the quality of evidence on the benefits of smoking cessation and THR has strengthened. Stopping tobacco use at any age is associated with longer survival, and switching to THR products is almost twice as effective for cessation as nicotine replacement therapies. While long-term studies on the health benefits of switching to THR are still needed, results of studies using biomarkers of future diseases are promising.

    The report comes at a critical time as many Middle East countries’ reverse bans on some THR products and liberalize their approach to tobacco alternatives. Meanwhile, new and innovative THR products are being developed for the Middle East signaling the growing acceptance of the value of THR and the demand for them by consumers.

    To benefit from the promise of these products the authors recommend educating physicians to communicate the benefits of THR to patients in all clinical encounters, countering disinformation about nicotine and the value of THR, and developing a regional equivalent of the Royal College of Physicians report on THR and vapes. The authors also recommend that policymakers revise regulations to improve access to THR products and invest in national science and research to replace tobacco with THR and establishing independent science-based consumer groups to advocate for their needs. The authors  encourage religious leaders to guide their communities to quit smoking and support tobacco harm reduction.

    “Embracing THR, cessation, and improved lung cancer treatment represents a major opportunity for the Middle East to dramatically improve the health of its populations,” said Derek Yach, lead author of the report, global health consultant and former senior WHO official. “The prevalence of smoking is projected to only decrease by less than 2 percentage, from 33.3 percent in 2020 to 31 percent in 2025. This preventable disaster should engender outrage and immediate action. This report aims to provide an alternative vision of what is possible.”

    Figure: Projected deaths from tobacco in 2060

    This figure shows the number of tobacco deaths expected to occur in 2060 using three scenarios: WHO projections using FCTC and MPOWER measures; WHO projections adding THR products; and WHO projection adding THR, smoking cessation and, lung cancer innovations.
  • Florida Governor Vetoes ‘Debilitating’ Delta-8 Ban Bill

    Florida Governor Vetoes ‘Debilitating’ Delta-8 Ban Bill

    Credit: Fokussiert

    Floridians will still have access to buying and using delta-8 and other hemp products as Gov. Ron DeSantis vetoed a bill that aimed to reshape Florida’s marketplace.

    As the bill, SB 1698, moved through Florida’s legislative process, it was opposed by consumers who said they need the products for their physical and mental health and by businesses that said it would cause thousands of Floridians to lose their jobs.

    DeSantis, based on his veto letter, seemed to agree. In the letter, DeSantis said the bill would “impose debilitating regulatory burdens on small businesses” and would “introduce dramatic disruption and harm to many small retail and manufacturing businesses in Florida.”

    A study commissioned by a hemp trade group found that Florida’s hemp market racked up more than $10 billion in sales in 2022 and employed more than 100,000 people, according to media reports.

    DeSantis said he would encourage the Legislature to return to the topic next session to create a regulatory framework for Florida’s hemp marketplace.

    “Sensible, non-arbitrary regulation will provide businesses and consumers alike with much-needed stability — safeguarding public health and safety, allowing legitimate industry to flourish, and removing bad actors from the market,” DeSantis said.

    He listed three areas he would like the Legislature to focus on: quality control, product packaging requirements and looking at how and where hemp products are sold.

  • Consumer Group Welcomes Juul Ban Rescission

    Consumer Group Welcomes Juul Ban Rescission

    Photo: Juul Labs

    The potential return of Juul to U.S. store shelves would represent a win for consumers and tobacco harm reduction, according to the Consumer Choice Center (CCC).

    On June 6, the U.S. Food and Drug Administration rescinded its 2022 marketing denial order. While the move it neither an authorization nor a denial, it places the company’s premarket tobacco product application back into scientific review, meaning it could potentially be authorized at some point.

    “This is a step in the right direction for consumers who want more nicotine alternatives to combustible tobacco,” said CCC U.S. Policy Analyst Elizabeth Hicks.

    The FDA said in its June 6 statement that it had “conducted additional substantive review of the applications in a number of disciplines, including toxicology, engineering, social science, and clinical pharmacology” and that their change of course is based on a “review of information provided by the applicant” plus new case law based on court decisions involving MDOs for e-cigarette products.

    “With over 26 million applications submitted to the FDA, less than 10 e-cigarette devices have been approved by the agency. Vaping is 95 percent less harmful than smoking combustible tobacco, and the FDA has an opportunity to help drastically improve public health by allowing consumers a choice when it comes to alternatives to combustible cigarettes,” said Hicks.

    The FDA decision opens the door for Juul to return to the market in the future, and allow U.S. consumers the same choice as those in the U.K. and Canada.

    “We hope the FDA provides a clear and transparent pathway for Juul Labs and the thousands of other companies who submitted product applications to finally gain authorization to offer their products to consumers in a regulated market,” concluded Hicks.

  • Namibia Readies to Regulate Vaping Products

    Namibia Readies to Regulate Vaping Products

    Image: sezerozger

    Namibia plans to regulate vapor products and water pipes, reports the Windhoek Observer.

    The country’s Ministry of Health and Social Services wants to amend the Tobacco Act to include those products.

    The goal is to curb the growing use of electronic cigarettes and water pipes across the country. The amendment will also facilitate the development of a comprehensive tobacco strategic plan scheduled for launch later this month.

    Deputy Minister of Health and Social Services Ester Muinjangue stressed the urgency of regulating vaping products, despite existing legal frameworks to combat tobacco use in Namibia. “There is no safe form of tobacco smoke,” she said, rejecting suggestions that vaping and hookah smoking are safer alternatives to traditional cigarette smoking.

    Muinjangue encouraged smokers seeking to quit their habit to utilize existing resources and seek support from health professionals.